FitzmauriceC,DickerD,PainA,HamavidH,Moradi-LakehM,MaclntyreMF,,2015,,JAMA Oncol,1,505-27
FormentiSC,ArsianAA,LoveSM,,2012,Global breast cancer: The lessons to bring home,Int J Breast Cancer,,249501-
PolyakK.,,2011,Heterogeneity in breast cancer,J Clin Invest,121,3786-8
TuragaK,AcsG,LarongaC,,2010,Gene expression profiling in breast cancer,Cancer Control,17,177-82
MillikanRC,NewmanB,TseCK,MoormanPG,ConwayK,DresslerLG,,2008,Epidemiology of basal-like breast cancer,Breast Cancer Res Treat,109,123-39
Piccart-Gebhart MJ,,2010,New Developments in Hormone ReceptorPositive Disease,Oncologist,15,18-28
SlamonD,EiermannW,RobertN,PienkowskiT,MartinM,PressM,,2011,Adjuvant trastuzumab in HER2-Positive breast cancer,N Engl J Med,365,1273-83
BangalVB,ShindeKK,GavhaneSP,SinghRK,,2013,Breast Carcinoma in women-A rising threat,Int J Biomed Adv Res,4,73-6
SchnittSJ,,2010,Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy,Mod Pathol,23,S560-4
AhmedR,Ud DinH,AkhtarF,AfzalS,MuhammadI,HashmiSN,,2016,Immunohistochemical expression of epidermal growth factot receptor and C-KIT in triple negative breast cancer,J Coll Physicians Surg Pak,26,570-2
JemalA,WardE,Thun MJ,,2007,Recent trends in breast cancer incidence rates by age and tumour characteristics among U.S women,Breast Cancer Res,9,R28-
LeeSK,BaeSY,LeeJH,LeeHC,YiH,KilWH,Low-Risk Luminal A Breast Cancer,,2015,Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival,PLoS One,10,e0124658-
WangJ,SangD,XuB,YuanP,MaF,LuY,,2016,Value of breast cancer Molecular Subtypes and Ki 67 expression in the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population,Medicine (Baltimore),95,e3518-
InicZ,ZegaracM,InicM,MarkovicI,KozomaraZ,DjurisicI,Luminal B Subtypes According,TumorSize,,2014,Difference between Luminal A,Clin Med Insights Oncol,8,107-11
AdesF,ZardavasD,Bozovic-SpasojevicI,PuglianoL,FumagalliD,AzambujaE,B BreastCancer: Molecular Characterization,ClinicalManagement,FuturePerspectives,,2014,,J Clin Oncol,32,2794-803
SuY,ZhengY,ZhengW,GuK,ChenZ,LiG,,2011,Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a populationbased cohort study,BMC Cancer,11,292-
WittonCJ,ReevesJR,GoingJJ,CookeTG,BartlettJM,,2003,Expression of the HER 1-4 family of receptor tyrosine kinases in breast cancer,J Pathol,200,290-7
ShokouhTZ,EzatollahA,BarandP.,Interrelationships BetweenKi67,,2015,HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: RetrospectiveObservational Analytical Study,Medicine (Baltimore),94,e1359-
Badowska-KozakiewiczAM,BudzikMP,,2016,Immunohistochemical characteristics of basal-like breast cancer,Contemp Oncol (Pozn),20,436-43
RakhaEA,El-SayedME,GreenAR,LeeAH,RobertsonJF,EllisIO,,2007,Prognostic markers in triple-negative breast cancer,Cancer,109,25-32
AlluriP,NewmanL,,2014,Basal-like and Triple Negative Breast Cancers: Searching For Positives Among Many Negatives,Surg Oncol Clin N Am,23,567-77